Department of Dermatology, University of Leeds, Leeds, United Kingdom., United Kingdom
Disclosure information not submitted.
The effectiveness of adalimumab biosimilars and originator for the treatment of Psoriasis: A target trial emulation study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Monday, August 26, 20245:25 PM – 5:30 PM CEST
